Serena Williams Faces Backlash Over GLP-1 Promotion Amid Weight-Loss Drug Concerns

Serena Williams has come under renewed scrutiny after fans criticized her endorsement of GLP-1 weight-loss drugs amid reports raising concerns about serious health complications associated with the medications.

The 23-time Grand Slam champion partnered with Ro, a digital health platform offering GLP-1 medications for weight management. During her time away from competitive Tennis, Williams also publicly discussed her personal experience with Zepbound, saying the medication helped her lose 34 pounds and improve her overall health.

Fans Question Serena Williams’ GLP-1 Promotion

GLP-1 medications have become increasingly popular as weight-loss treatments, but they have also faced growing scrutiny over potential side effects and legal claims. Reports cited in the original article state that law firms have been accepting claims involving conditions such as gastroparesis and vision problems.

Sky Sports has also reported that more than 200 deaths are suspected to be linked to weight-loss injections. These reports have fueled further debate online, with some fans questioning whether high-profile celebrities should promote GLP-1 medications.

Several users on X criticized Williams for her association with the products, arguing that celebrities have a responsibility to consider the potential risks when promoting widely marketed health treatments.

However, reports of suspected associations do not by themselves establish that GLP-1 medications caused those deaths. Individual risks and benefits can vary, and medication decisions should be discussed with qualified healthcare professionals.

Serena Williams Preparing for Cincinnati Return

Amid the controversy away from tennis, Williams is preparing for a highly anticipated return to competitive action alongside her sister Venus Williams.

The Williams sisters have received a women’s doubles wildcard for the Cincinnati Open, which begins on August 11. Their appearance will mark the first time the legendary siblings are expected to reunite on court in four years.

Serena recently returned to competitive tennis after a four-year absence, making her singles comeback at Wimbledon. She faced Maya Joint in London but ultimately lost a closely contested three-set match, 3-6, 7-6(6), 3-6.

Williams also suffered a knee issue during the match, which prevented her from recovering in time to compete alongside Venus in the Wimbledon doubles event.

Williams Sisters Set for Cincinnati Reunion

With Venus now joining her in Cincinnati, Serena will look to put her recent setback behind her and enjoy another opportunity to compete on the professional stage.

The sisters remain among the most accomplished doubles partnerships in women’s tennis, and their return is expected to generate significant attention as Serena continues her comeback following her lengthy absence.